Evidence map›Paper›PMID 42441203›Full record

ReviewClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2026

Uterine artery pulsatility index as a functional biomarker of central precocious puberty: a scoping review.

Ignazio Cammisa, Donato Rigante, Clelia Cipolla

Abstract readReview
In one paragraph

Review in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ignazio CammisaDepartment of Pediatrics, San Giovanni Evangelista Hospital, Tivoli, Italy.
Donato RiganteDepartment of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Clelia CipollaDepartment of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central precocious puberty (CPP) results from the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis. Although the GnRH stimulation test remains the gold standard for diagnosis, the uterine artery pulsatility index (PI) has been proposed as a functional indicator of pubertal activation. The aim of this review, which included 11 studies and 1,151 patients, was to summarize the current evidence regarding the diagnostic role of uterine artery PI in CPP evaluation. A consistent inverse relationship was observed between the PI and pubertal progression. The reported PI sensitivity for detecting pubertal onset ranges from 77% to 100%, while the specificity varies between 48% and 100%, depending on the cutoff values and study populations. Diagnostic accuracy improved when the PI was combined with uterine morphometric parameters. In girls with CPP undergoing GnRH agonist therapy, the PI increased significantly during treatment, suggesting its potential role as a marker of therapeutic response. Thus, uterine artery PI represents a physiologically plausible and clinically informative adjunctive tool that suggests HPG axis activation. Although not suitable as a stand-alone diagnostic test, its integration into a multimodal diagnostic framework may enhance the non invasive evaluation and monitoring of CPP.

Indexed as

central precocious pubertypelvic ultrasoundprecision medicinepubertyuterine artery pulsatility index

Identifiers

PMID42441203
PMCPMC13337298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.